Similarly, circulating progenitor cells are decreased in patients with severe lung disease29 and lower CD34+ HSPCs were associated with a more than 3-fold higher risk of adverse outcome in patients with coronavirus disease 2019 (COVID-19). The gene discussed is CD34; the disease is COVID-19.